New azolyl-derivatives as multitargeting agents against breast cancer and fungal infections: synthesis, biological evaluation and docking study

Nonsteroidal aromatase inhibitors (NSAIs) are well-established drugs for the therapy of breast cancer. However, they display some serious side effects, and their efficacy can be compromised by the development of chemoresistance. Previously, we have reported different indazole-based carbamates and pi...

Descripción completa

Detalles Bibliográficos
Autores principales: Maccallini, Cristina, Gallorini, Marialucia, Sisto, Francesca, Akdemir, Atilla, Ammazzalorso, Alessandra, De Filippis, Barbara, Fantacuzzi, Marialuigia, Giampietro, Letizia, Carradori, Simone, Cataldi, Amelia, Amoroso, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300937/
https://www.ncbi.nlm.nih.gov/pubmed/34289751
http://dx.doi.org/10.1080/14756366.2021.1954918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300937/
https://www.ncbi.nlm.nih.gov/pubmed/34289751
http://dx.doi.org/10.1080/14756366.2021.1954918

Ejemplares similares